Skip to content

01 · Diagnose

Cannabis Route-to-Market Review

Map the route. Find the constraint. Leave with a focused 90-day commercial intervention plan.

Current test · R20,000 upfront
Directional tool · not the paid diagnostic

Where is the commercial system leaking?

Six questions. No email gate. Use the result to decide whether the expensive problem is worth a proper review.

01
Position

Can a qualified buyer understand what you sell, who it is for and why it is worth choosing?

Offer clarity and commercial positioning.

02
Buyer

Do you know which accounts or customer segments deserve attention first?

Buyer priority, account selection and economics.

03
Route

Is there a clear route from product to customer — direct, retail, wholesale, partner or distribution?

Route-to-market and availability.

04
Pipeline

Can you see opportunities moving through a defined sales process with consistent follow-up?

Pipeline, CRM and revenue rhythm.

05
Partners

Are partnerships and channels actively producing access, credibility or revenue?

Business development and channel leverage.

06
Ownership

Does somebody clearly own each handoff between interest, sale, fulfilment and repeat business?

Commercial accountability and operating handoffs.

Answer all six to reveal the commercial signal.

Use it when

The business is moving, but the route is not clear.

AtlasFlow reviews positioning, buyer logic, channels, partnerships, sales, pipeline and follow-up to identify the commercial constraint most worth fixing first.

Request the review
01

Map

Current commercial route, buyers, channels and handoffs.

02

Diagnose

Separate the expensive constraint from background noise.

03

Prioritise

Choose the highest-value intervention and success evidence.

04

Decide

Implement internally, run a sprint, or stop.

Commercial strategy only. No medical, legal, pharmacy or regulatory approval.